Sunshine Biopharma Inc. Scheduled to Announce Q3 2026 Financial Results
Sunshine Biopharma Inc. has scheduled the release of its third-quarter 2026 financial results for November 10, 2026.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Sunshine Biopharma Inc. has scheduled the release of its third-quarter 2026 financial results for November 10, 2026.
U.S. stocks fell Thursday as Nasdaq slid 150+ points; energy rallied, healthcare dropped. PepsiCo beat estimates but cut FY26 outlook; oil jumped 5%.
U.S. stocks fell Thursday, led by tech, while energy rose and oil jumped 4.8%. Jobless claims eased to 197,000; small caps posted sharp swings.